Tag: pulmonary disease
BioCardia announces FDA review completion of ongoing cell therapy for heart...
BioCardia, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, has announced that the US Food and Drug...